期刊文献+

甲状腺肿瘤患者血清中MBL和MASP-2的表达水平及其意义(英文)

Expressions and clinical significances of mannose-binding lectin(MBL) and MBL-associated serine protease 2(MASP-2) in patients with thyroid neoplasm
下载PDF
导出
摘要 Objective:The aim of the study was to detect the levels of mannose-binding lectin(MBL),MBL-associated serine protease 2(MASP-2) and explore the clinical significances of them in patients with primary thyroid neoplasms.Methods:By using ELISA method,we detected the serum levels of MBL and MASP-2 in 26 patients with papillary thyroid carcinoma(PTC),30 patients with thyroid adenoma(TA) and 26 healthy people,respectively.Results:Serum MBL level was(565.23 ± 76.70) μg/L in PTCs higher than(324.267 ± 24.74) μg/L in TAs,and(152.69 ± 16.95) μg/L in healthy of controlling group.There was statistical significance between PTC and TA(P < 0.05),however there was no difference between TA and healthy(P > 0.05).Serum MASP-2 level was(726.153 ± 78.88) μg/L in PTCs higher than(379.266 ± 30.26) μg/L in TAs,and(203.846 ± 29.09) μg/L in healthy.Serum MASP-2 level was higher in PTCs than TAs,and the difference had statistical significance(P < 0.01).But no difference was observed between in TAs and healthy.Conclusion:These findings might reflect inflammatory processes induced by defense mechanisms,in response to the development of the tumour.MBL may also be involved in the elimination of possible tumourigenic pathogens. Objective: The aim of the study was to detect the levels of mannose-binding lectin (MBL), MBL-associated serine protease 2 (MASP-2) and explore the clinical significances of them in patients with primary thyroid neoplasms. Methods: By using ELISA method, we detected the serum levels of MBL and MASP-2 in 26 patients with papillary thyroid carcinoma (PTC), 30 patients with thyroid adenoma (TA) and 26 healthy people, respectively. Results: Serum MBL level was (565.23 ± 76.70) μg/L in PTCs higher than (324.267 ±24.74) μg/L in TAs, and (152.69± 16.95) IJg/L in healthy of controlling group. There was statistical significance between PTC and TA (P 〈 0.05), however there was no difference between TA and healthy (P 〉 0.05). Serum MASP-2 level was (726.153± 78.88) pg/L in PTCs higher than (379.266 ± 30.26) μg/L in TAs, and (203.846 ± 29.09) μg/L in healthy. Serum MASP-2 level was higher in PTCs than TAs, and the difference had statistical significance (P 〈 0.01). But no difference was observed between in TAs and healthy. Conclusion: These findings might reflect inflammatory processes induced by defense mechanisms, in response to the development of the turnout. MBL may also be involved in the elimination of possible tumourigenic pathogens.
出处 《The Chinese-German Journal of Clinical Oncology》 CAS 2013年第3期106-108,共3页 中德临床肿瘤学杂志(英文版)
基金 Supported by a grant of Natural Science Funds Projects of Hebei Province (No. C2008001306)
关键词 甘露糖结合凝集素 丝氨酸蛋白酶 肿瘤患者 临床意义 MBL 甲状腺 酶联免疫吸附法 技术援助 thyroid neoplasm mannose-binding lectin (MBL) MBL-associated serine protease 2 (MASP-2) detection
  • 相关文献

参考文献7

  • 1Turner MW. The role of mannose-binding lectin in health and disease. Mol Immunol, 2003, 40: 423-429.
  • 2Bergmann O J, Christiansen M, Laursen I, et al. Low levels of man- nose-binding lecUn do not affect occurrence of severe infections or duration of fever in acute myeloid leukaemia during remission induc- tion therapy. Eur J Haematol, 2003, 70: 91-97.
  • 3Neth O, Hann I, Turner MW, et al. Deficiency of mannose-binding lec- tin and burden of infection in children with malignancy: a prospective study. Lancet, 2001, 358: 614-618.
  • 4Swierzko AS, Florczak K, Cedzy~ski M, et al. Mannan-binding lectin (MBL) in women with tumours of the reproductive system. Cancer Immunol Immunother. 2007.56: 959-971.
  • 5Ytting H, Jensenius JC, Christensen I J, et al. Increased activity of the mannan-binding lectin complement activation pathway in patients with colorectal cancer. Scand J Gastroenterol, 2004, 39: 674-679.
  • 6Ytting H, Christensen I J, Thiel S, et al. Biological variation in circulat- ing levels of mannan-binding lectin (MBL) and MBL-associated serine protease-2 and the influence of age, gender and physical exercise. Scand J Immunol, 2007, 66: 458-464.
  • 7Vorup-Jensen T, Jensenius JC, Thiel S. MASP-2, the C3 convertase generating protease of the MBLectin complement activating pathway. Immunobiology, 1998, 199: 348-357.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部